Skip to content

The Role of shLAIR-1 and hLAIR-2 in IBD

The Role of shLAIR-1 and hLAIR-2 in IBD - shLAIR-1 and hLAIR-2 in IBD

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36469
Enrollment
60
Registered
2011-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Intestinal Disorder Inflammatory bowel disease

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 18 years or older Established diagnosis of Crohn's disease or ulcerative colitis Clinical indication for colonoscopy

Exclusion criteria

Exclusion criteria: (Sub)total colectomy Ileostomy/ colostomy Active disease activity in the proximal part of the GI tract

Design outcomes

Primary

MeasureTime frame
Concentration of urinary shLAIR-1 and hLAIR2, clinical and endoscopic disease activity scores

Secondary

MeasureTime frame
None.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)